Lv72
3530 积分 2023-03-27 加入
Tumor-expressed GPNMB orchestrates Siglec-9 + TAM polarization and EMT to promote metastasis in triple-negative breast cancer
5天前
已完结
Small-Molecule Inhibitors Targeting RNA m6A Modifiers for Cancer Therapeutics: Latest Advances and Future Perspectives
11天前
已完结
PI3K/AKT/mTOR inhibitors for hormone receptor-positive advanced breast cancer
25天前
已完结
Capivasertib: A Novel AKT Inhibitor Approved for Hormone-Receptor-Positive, HER-2-Negative Metastatic Breast Cancer
25天前
已完结
Capivasertib: First Approved AKT inhibitor for the Treatment of Patients with Breast Cancer
25天前
已完结
Medicinal Chemistry behind Capivasertib Discovery: Seventh Magic Bullet of the Fragment-based Drug Design Approved for Oncology
25天前
已完结
An overview of RAF kinases and their inhibitors (2019-2023)
26天前
已完结
Discovery of the First Potent ROR1 Degrader for the Treatment of Non-Small Cell Lung Cancer
27天前
已完结
Paxalisib. PI3K/mTOR inhibitor, Treatment of gliomas
1个月前
已关闭
The Evolution of Small-Molecule Akt Inhibitors from Hit to Clinical Candidate
1个月前
已关闭
皖公网安备34019202002308
